Loss of β-arrestin2 mediates pancreatic-islet dysfunction in mice

Biochemical and Biophysical Research Communications

Volumn 435, Issue 3, 2013, Pages 345-349

  Zhang, Mingliang ^a,b,c   Zhu, Yunxia ^a,b,c   Mu, Kaida ^a,b,c   Li, Ling ^a,b,c   Lu, Junxi ^a,b,c   Zhao, Jian ^d   Huang, Xinyi ^e   Wang, Chen ^a,b,c   Jia, Weiping ^a,b,c  

^a SHANGHAI JIAO TONG UNIVERSITY AFFILIATED SIXTH PEOPLE S HOSPITAL   (China)

^b SHANGHAI JIAO TONG UNIVERSITY   (China)

^c Shanghai Key Laboratory of Diabetes Mellitus   (China)

^d INSTITUTE OF BIOCHEMISTRY AND CELL BIOLOGY   (China)

^e UNIVERSITY OF TORONTO   (Canada)

Author keywords

Arrestin2; Exocytosis; Hyperglycemic clamp; Insulin secretion

Indexed keywords

BETA ARRESTIN 2; INSULIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL FUNCTION; CONTROLLED STUDY; DOWN REGULATION; HYPERGLYCEMIA; INSULIN RELEASE; MALE; MOUSE; NONHUMAN; OBESITY; PANCREAS INSUFFICIENCY; PANCREAS ISLET; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN EXPRESSION; REGULATORY MECHANISM;

ANIMALS; ARRESTINS; DIABETES MELLITUS, TYPE 2; INSULIN; INSULIN RESISTANCE; INSULIN-SECRETING CELLS; ISLETS OF LANGERHANS; MALE; MICE; MICE, KNOCKOUT; MICE, OBESE; OBESITY;

MUS;

EID: 84878983688     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2013.04.079     Document Type: Article

References (31)

1. Kahn S.E. The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of Type 2 diabetes. Diabetologia 2003, 46:3-19.
2. Prentki M., Nolan C.J. Islet beta cell failure in type 2 diabetes. J Clin. Invest. 2006, 116:1802-1812.
3. Goodman O.B., Krupnick J.G., Santini F., Gurevich V.V., Penn R.B., Gagnon A.W., Keen J.H., Benovic J.L. Beta-arrestin acts as a clathrin adaptor in endocytosis of the beta2-adrenergic receptor. Nature 1996, 383:447-450.
4. Hupfeld C.J., Olefsky J.M. Regulation of receptor tyrosine kinase signaling by GRKs and beta-arrestins. Annu. Rev. Physiol. 2007, 69:561-577.
5. Malik R., Marchese A. Arrestin-2 interacts with the endosomal sorting complex required for transport machinery to modulate endosomal sorting of CXCR4. Mol. Biol. Cell 2010, 21:2529-2541.
6. Gao H., Sun Y., Wu Y., Luan B., Wang Y., Qu B., Pei G. Identification of beta-arrestin2 as a G protein-coupled receptor-stimulated regulator of NF-kappaB pathways. Mol. Cell 2004, 14:303-317.
7. Coureuil M., Lecuyer H., Scott M.G., Boularan C., Enslen H., Soyer M., Mikaty G., Bourdoulous S., Nassif X., Marullo S. Meningococcus Hijacks a beta2-adrenoceptor/beta-arrestin pathway to cross brain microvasculature endothelium. Cell 2010, 143:1149-1160.
8. DeWire S.M., Ahn S., Lefkowitz R.J., Shenoy S.K. Beta-arrestins and cell signaling. Annu. Rev. Physiol. 2007, 69:483-510.
9. Usui I., Imamura T., Huang J., Satoh H., Shenoy S.K., Lefkowitz R.J., Hupfeld C.J., Olefsky J.M. Beta-arrestin-1 competitively inhibits insulin-induced ubiquitination and degradation of insulin receptor substrate 1. Mol. Cell. Biol. 2004, 24:8929-8937.
10. Sonoda N., Imamura T., Yoshizaki T., Babendure J.L., Lu J.C., Olefsky J.M. Beta-arrestin-1 mediates glucagon-like peptide-1 signaling to insulin secretion in cultured pancreatic beta cells. Proc. Natl. Acad. Sci. USA 2008, 105:6614-6619.
11. Luan B., Zhao J., Wu H., Duan B., Shu G., Wang X., Li D., Jia W., Kang J., Pei G. Deficiency of a beta-arrestin-2 signal complex contributes to insulin resistance. Nature 2009, 457:1146-1149.
12. Henquin J.C., Nenquin M., Stiernet P., Ahren B. In vivo and in vitro glucose-induced biphasic insulin secretion in the mouse: pattern and role of cytoplasmic Ca2+ and amplification signals in beta-cells. Diabetes 2006, 55:441-451.
13. Alonso-Magdalena P., Ropero A.B., Carrera M.P., Cederroth C.R., Baquie M., Gauthier B.R., Nef S., Stefani E., Nadal A. Pancreatic insulin content regulation by the estrogen receptor ER alpha. PLoS ONE 2008, 3:e2069.
14. Okada T., Liew C.W., Hu J., Hinault C., Michael M.D., Krtzfeldt J., Yin C., Holzenberger M., Stoffel M., Kulkarni R.N. Insulin receptors in beta-cells are critical for islet compensatory growth response to insulin resistance. Proc. Natl. Acad. Sci. USA 2007, 104:8977-8982.
15. Straub S.G., Shanmugam G., Sharp G.W. Stimulation of insulin release by glucose is associated with an increase in the number of docked granules in the beta-cells of rat pancreatic islets. Diabetes 2004, 53:3179-3183.
16. Zhou Y.P., Berggren P.O., Grill V. A fatty acid-induced decrease in pyruvate dehydrogenase activity is an important determinant of beta-cell dysfunction in the obese diabetic db/db mouse. Diabetes 1996, 45:580-586.
17. Wang L., Liu Y., Yan Lu S., Nguyen K.T., Schroer S.A., Suzuki A., Mak T.W., Gaisano H., Woo M. Deletion of Pten in pancreatic ss-cells protects against deficient ss-cell mass and function in mouse models of type 2 diabetes. Diabetes 2010, 59:3117-3126.
18. Gunton J.E., Kulkarni R.N., Yim S., Okada T., Hawthorne W.J., Tseng Y.H., Roberson R.S., Ricordi C., O'Connell P.J., Gonzalez F.J., Kahn C.R. Loss of ARNT/HIF1beta mediates altered gene expression and pancreatic-islet dysfunction in human type 2 diabetes. Cell 2005, 122:337-349.
19. Muller D., Huang G.C., Amiel S., Jones P.M., Persaud S.J. Gene expression heterogeneity in human islet endocrine cells in vitro: the insulin signaling cascade. Diabetologia 2007, 50:1239-1242.
20. Porzio O., Federici M., Hribal M.L., Lauro D., Accili D., Lauro R., Borboni P., Sesti G. The Gly972→Arg amino acid polymorphism in IRS-1 impairs insulin secretion in pancreatic beta cells. J Clin. Invest. 1999, 104:357-364.
21. Bouche C., Lopez X., Fleischman A., Cypess A.M., O'Shea S., Stefanovski D., Bergman R.N., Rogatsky E., Stein D.T., Kahn C.R., Kulkarni R.N., Goldfine A.B. Insulin enhances glucose-stimulated insulin secretion in healthy humans. Proc. Natl. Acad. Sci. USA 2010, 107:4770-4775.
22. Halperin F., Lopez X., Manning R., Kahn C.R., Kulkarni R.N., Goldfine A.B. Insulin augmentation of glucose-stimulated insulin secretion is impaired in insulin-resistant humans. Diabetes 2012, 61:301-309.
23. Kaneko K., Ueki K., Takahashi N., Hashimoto S., Okamoto M., Awazawa M., Okazaki Y., Ohsugi M., Inabe K., Umehara T., Yoshida M., Kakei M., Kitamura T., Luo J., Kulkarni R.N., Kahn C.R., Kasai H., Cantley L.C., Kadowaki T. Class IA phosphatidylinositol 3-kinase in pancreatic beta cells controls insulin secretion by multiple mechanisms. Cell Metab. 2010, 12:619-632.
24. Kulkarni R.N., Bruning J.C., Winnay J.N., Postic C., Magnuson M.A., Kahn C.R. Tissue-specific knockout of the insulin receptor in pancreatic beta cells creates an insulin secretory defect similar to that in type 2 diabetes. Cell 1999, 96:329-339.
25. Leibiger I.B., Leibiger B., Berggren P.O. Insulin signaling in the pancreatic beta-cell. Annu. Rev. Nutr. 2008, 28:233-251.
26. Cheng K.K., Lam K.S., Wu D., Wang Y., Sweeney G., Hoo R.L., Zhang J., Xu A. APPL1 potentiates insulin secretion in pancreatic beta cells by enhancing protein kinase Akt-dependent expression of SNARE proteins in mice. Proc. Natl. Acad. Sci. USA 2012, 109:8919-8924.
27. Liew C.W., Bochenski J., Kawamori D., Hu J., Leech C.A., Wanic K., Malecki M., Warram J.H., Qi L., Krolewski A.S., Kulkarni R.N. The pseudokinase tribbles homolog 3 interacts with ATF4 to negatively regulate insulin exocytosis in human and mouse beta cells. J Clin. Invest. 2010, 120:2876-2888.
28. Ahren B. Islet G protein-coupled receptors as potential targets for treatment of type 2 diabetes. Nat. Rev. Drug Discov. 2009, 8:369-385.
29. Itoh Y., Kawamata Y., Harada M., Kobayashi M., Fujii R., Fukusumi S., Ogi K., Hosoya M., Tanaka Y., Uejima H., Tanaka H., Maruyama M., Satoh R., Okubo S., Kizawa H., Komatsu H., Matsumura F., Noguchi Y., Shinohara T., Hinuma S., Fujisawa Y., Fujino M. Free fatty acids regulate insulin secretion from pancreatic beta cells through GPR40. Nature 2003, 422:173-176.
30. Chu Z.L., Jones R.M., He H., Carroll C., Gutierrez V., Lucman A., Moloney M., Gao H., Mondala H., Bagnol D., Unett D., Liang Y., Demarest K., Semple G., Behan D.P., Leonard J. A role for beta-cell-expressed G protein-coupled receptor 119 in glycemic control by enhancing glucose-dependent insulin release. Endocrinology 2007, 148:2601-2609.
31. Broca C., Quoyer J., Costes S., Linck N., Varrault A., Deffayet P.M., Bockaert J., Dalle S., Bertrand G. Beta-arrestin 1 is required for PAC1 receptor-mediated potentiation of long-lasting ERK1/2 activation by glucose in pancreatic beta-cells. J. Biol. Chem. 2009, 284:4332-4342.